VCP suppresses proteopathic seeding in neurons

[1]  Terrance T. Kummer,et al.  Neuronal VCP loss of function recapitulates FTLD-TDP pathology , 2021, Cell reports.

[2]  P. van Damme,et al.  TDP-43 proteinopathies: a new wave of neurodegenerative diseases , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  M. Grossman,et al.  Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau , 2020, Science.

[4]  S. Radford,et al.  Brazilin Removes Toxic alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium , 2020, bioRxiv.

[5]  M. Cookson,et al.  The Parkinson’s Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network , 2020, Cell reports.

[6]  Andreas Martin,et al.  Multisystem Proteinopathy Mutations in VCP/p97 Increase NPLOC4·UFD1L Binding and Substrate Processing. , 2019, Structure.

[7]  E. Colla.  Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy , 2019, Front. Neurosci..

[8]  Nicolas L. Fawzi,et al.  TDP-43 α-helical structure tunes liquid–liquid phase separation and function , 2019, Proceedings of the National Academy of Sciences.

[9]  Marco Y. Hein,et al.  Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation , 2019, The Journal of Biological Chemistry.

[10]  P. Kotzbauer,et al.  Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation , 2019, The Journal of Biological Chemistry.

[11]  M. Bickle,et al.  Unbiased Screens for Modifiers of Alpha-Synuclein Toxicity , 2019, Current Neurology and Neuroscience Reports.

[12]  H. Meyer,et al.  VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle , 2019, Autophagy.

[13]  N. Cairns,et al.  Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics , 2018, The Journal of Biological Chemistry.

[14]  J. Trojanowski,et al.  Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo , 2018, Nature Communications.

[15]  Maxime W. C. Rousseaux,et al.  A Druggable Genome Screen Identifies Modifiers of α-Synuclein Levels via a Tiered Cross-Species Validation Approach , 2018, The Journal of Neuroscience.

[16]  H. Fuchs,et al.  The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice? , 2018, Biochemical and biophysical research communications.

[17]  P. Hanson,et al.  Triggered recruitment of ESCRT machinery promotes endolysosomal repair , 2018, Science.

[18]  D. Dickson,et al.  Impaired endo-lysosomal membrane integrity accelerates the seeding progression of α-synuclein aggregates , 2017, Scientific Reports.

[19]  J. Kordower,et al.  Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins , 2017, Acta Neuropathologica.

[20]  P. Kotzbauer,et al.  A sensitive assay reveals structural requirements for α-synuclein fibril growth , 2017, The Journal of Biological Chemistry.

[21]  Prashant Mishra,et al.  Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants , 2017, eLife.

[22]  I. Ferrer,et al.  Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms , 2017, Front. Neurol..

[23]  M. Ehrmann,et al.  VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy , 2017, The EMBO journal.

[24]  V. Deretic,et al.  TRIMs and Galectins Globally Cooperate and TRIM16 and Galectin-3 Co-direct Autophagy in Endomembrane Damage Homeostasis. , 2016, Developmental cell.

[25]  M. Diamond,et al.  Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry. , 2015, Journal of visualized experiments : JoVE.

[26]  Daniel J. Anderson,et al.  Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083). , 2015, Journal of medicinal chemistry.

[27]  A. Aulas,et al.  Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? , 2015, Front. Cell. Neurosci..

[28]  D. Geschwind,et al.  Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism , 2015, Proceedings of the National Academy of Sciences.

[29]  J. Trojanowski,et al.  Spreading of pathology in neurodegenerative diseases: a focus on human studies , 2015, Nature Reviews Neuroscience.

[30]  H. Meyer,et al.  The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis , 2014, Journal of Cell Science.

[31]  K. Luk,et al.  Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite–like aggregates , 2014, Nature Protocols.

[32]  C. Huisingh,et al.  ATP6V0C Knockdown in Neuroblastoma Cells Alters Autophagy-Lysosome Pathway Function and Metabolism of Proteins that Accumulate in Neurodegenerative Disease , 2014, PloS one.

[33]  A. Isacchi,et al.  Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. , 2013, Nature chemical biology.

[34]  R. Parker,et al.  Eukaryotic Stress Granules Are Cleared by Autophagy and Cdc48/VCP Function , 2013, Cell.

[35]  J. Platt,et al.  Genotype–phenotype studies of VCP‐associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia , 2013, Clinical genetics.

[36]  Michael Benatar,et al.  Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.

[37]  R. Mach,et al.  Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent , 2013, PloS one.

[38]  S. DeKosky,et al.  Phenotypic variability in three families with valosin‐containing protein mutation , 2013, European journal of neurology.

[39]  V. Kimonis,et al.  A progressive translational mouse model of human valosin‐containing protein disease: The VCPR155H/+ mouse , 2013, Muscle & nerve.

[40]  R. Deshaies,et al.  Structure–Activity Relationship Study Reveals ML240 and ML241 as Potent and Selective Inhibitors of p97 ATPase , 2013, ChemMedChem.

[41]  Y. Itoyama,et al.  Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy , 2012, Molecular Neurodegeneration.

[42]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[43]  R. Aebersold,et al.  Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations , 2011, Nature Cell Biology.

[44]  Steven J Brown,et al.  Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways , 2011, Proceedings of the National Academy of Sciences.

[45]  A. Pestronk,et al.  Valosin-containing protein disease: Inclusion body myopathy with Paget’s disease of the bone and fronto-temporal dementia , 2009, Neuromuscular Disorders.

[46]  Sara E. Miller,et al.  Impaired Protein Aggregate Handling and Clearance Underlie the Pathogenesis of p97/VCP-associated Disease* , 2008, Journal of Biological Chemistry.

[47]  A. Pestronk,et al.  TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[48]  Qiuyan Wang,et al.  Inhibition of p97-dependent Protein Degradation by Eeyarestatin I* , 2008, Journal of Biological Chemistry.

[49]  J. Hay.  Faculty Opinions recommendation of Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. , 2007 .

[50]  N. Cairns,et al.  TDP‐43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations , 2007, Journal of neuropathology and experimental neurology.

[51]  S. Kaech,et al.  Culturing hippocampal neurons , 2006, Nature Protocols.

[52]  A. Kudlicki,et al.  Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. , 2006, Molecular biology of the cell.

[53]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[54]  Charles D. Smith,et al.  Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations , 2006, Journal of neuropathology and experimental neurology.

[55]  A. Pestronk,et al.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.

[56]  Michel Goedert,et al.  Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.

[57]  Emily A. Scarborough,et al.  Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013 .

[58]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..